Pharmaceutical grade Tranexamic acid
Trade name：TraxmicTM
INCI NAME：Tranexamic Acid
Molecular formula: C8H15NO2
Molecular weight: 157.21
CAS：1197-18-8
Quality standard: CP2010/BP/EP/ JP/USP
Character: White crystalline powder,almost tasteless
Solubility: Easily soluble in water
Application in the field of medicine:
Our company specializes in producing high quality Tranexamic acid raw materials. The products conform to CP2010, USP42, BP2019, JP17, EP9.0 Pharmacopoeia standards and are manufactured according to GMP standards.
Tranexamic acid strongly adsorbs to the lysine binding site (LBS) of the fibrin affinity site on plasmin and plasminogen, preventing the binding of plasmin, plasminogen and fibrin, thereby strongly inhibiting the fibrin degradation caused by plasmin.
In addition, since the anti-plasmin in serum, such as macroglobulin, Tranexamic acid is more resistant to fibrinolysis. Therefore, compared with traditional Aminomethylbenzoic acid, it has a wider range of hemostasis effect, quicker, and with less side effects.
Moreover, Tranexamic acid has a certain effect on treatment of tonsil inflammation, tuberculosis,hemoptysis, hemorrhoids, chloasma and the like. Hemostatic medicine in global pharmaceutical field.
Your present position：